Table 2: Distribution of clinical and immunological characteristics of study participants.
|
Variables |
Frequency |
Percentage % |
|
|
Cd4 Category |
< 200 |
152 |
48% |
|
200-300 |
91 |
28.7% |
|
|
> 300 |
74 |
23.3% |
|
|
BMI Category |
< 18.5 |
76 |
24.0% |
|
>= 18.5 |
241 |
76.0% |
|
|
Month Since Dignosis |
<= 12 |
305 |
96.2% |
|
> 12 |
12 |
3.8% |
|
|
Who Clinical Stage |
Stage 1 |
131 |
41.3% |
|
Stage 2 |
48 |
15.1% |
|
|
Stage 3 |
95 |
30.0% |
|
|
Stage 4 |
43 |
13.6% |
|
|
Functional Status |
Working |
224 |
70.7% |
|
Ambulatory |
76 |
24.0% |
|
|
Bed ridden |
17 |
5.3% |
|
|
Presence of Opportunities Infection |
Yes |
196 |
61.8% |
|
No |
121 |
38.2% |
|
|
Tb co-infection |
Yes |
79 |
24.9% |
|
No |
238 |
75.1% |
|